Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes

Diabetes Care

Volumn 21, Issue 12, 1998, Pages 2056-2061

  Kelley, David E ^a   Bidot, Pascual ^c   Freedman, Zachary ^d   Haag, Burritt ^e   Podlecki, David ^f   Rendell, Marc ^g   Schimel, David ^h   Weiss, Stuart ⁱ   Taylor, Terry ^b   Krol, Alice ^b   Magner, James ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BAYER CORPORATION   (United States)

^c Florida Pharmaceutical Research   (United States)

^d Genesee Hospital   (United States)

^e BAYSTATE MEDICAL CENTER   (United States)

^f Longmont Medical Research Network   (United States)

^g CREIGHTON UNIVERSITY   (United States)

^h Midwest Clinical Research Institute   (United States)

ⁱ S Diego Endocr and Medical Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031767296     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.12.2056     Document Type: Article

References (22)

1. Dinneen S, Gerich J, Rizza R: Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327:707-713, 1992
2. Kelley D, Mokan M, Veneman T: Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 43:1549-1557, 1994
3. Ferrannini E, Simonson DC, Katz, LD, Reichard G Jr, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA: The disposal of oral glucose load in patients with non-insulin- dependent diabetes. Metabolism 37:79-85, 1988
4. Firth RG, Bell M, Marsh HM, Hansen I, Rizza RA: Postprandial hyperglycemia in patients with non-insulin-dependent diabetes mellitus. J Clin invest 77:1525-1532, 1986
5. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J: Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
6. Tan M-H: α-Glucosidase inhibitors in the treatment of diabetes. Curr Opin Endocrinol Diabetes 4:48-55, 1997
7. Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM: The efficacy of acarbose in the treatment of patients with non-insulin- dependent diabetes mellitus: a multicenter controlled clinical trial. Ann Intern Med 121:928-935, 1994
8. Coniff RF, Shapiro JA, Seaton TB, Bray GA: Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acar- bose in non-insulin-dependent diabetes mellitus. Am J Med 98:443-451, 1995
9. Coniff RF, Shapiro JA, Seaton TB: Long- term efficacy and safety of acarbose in the treatment of obese subjects with non- insulin-dependent diabetes mellitus, Arch Intern Med 154:2442-2448, 1994
10. Lebovitz HE: α-Glucosidase inhibitors. Endocrinol Metab Clin North Am 26:539-551, 1997
11. Hoffmann J, Spengler M: Efficacy of 24- week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study. Am J Med 103:483-490, 1997
12. Coniff RF, Shapiro JA, Seaton TB, Hoogwerf BJ, Hunt JA: A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes. Diabetes Care 18:928-932, 1995
13. Hara T, Nakamura J, Koh N, Sakakibara F, Takeuchi N, Hotta N: An importance of carbohydrate ingestion for the expression of the effect of α-glucosidase inhibitor in NIDDM. Diabetes Care 19:642-647, 1996
14. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
15. American Diabetes Association: Nutrition recommendations and principles for people with diabetes mellitus (Position Statement). Diabetes Care 20 (Suppl. 1):S14-S17, 1997
16. United Kingdom Prospective Diabetes Study Group: United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy Ann Intern Med 128:165-175, 1998
17. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin, SR, Henderson W, Lee HS: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 18:1113- 1123, 1995
18. Riddle M: Tactics for type II diabetes. Endocrinol Metab Clin North Am 26:659-677, 1997
19. Clauson PG, Linde B: Absorption of rapid-acting insulin in obese and nonobese NIDDM patients. Diabetes Care 18:986-991, 1995
20. Hollander P, Pi-Sunyer X, Coniff RF: Acarbose in the treatment of type I diabetes. Diabetes Care 20:248-253, 1997
21. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
22. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995